rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jason Adair

Chief Business Officer

Company insider

Files Form 4 as: Chief Business Officer, Liquidia.

Every Form 4 they filed

In numbers

Trades disclosed
173
Buys
0
Sells
39
Bought
$0
Sold
$15.7M
Companies
1
Companies where not an officer
0
First trade
21 Jul 2021
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
LQDA LiquidiaOfficer · Biotechnology · last 12 Oct 20260 buys · 39 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$208K7,301 at $28.48filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,906filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—2,474filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,868filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,906 at $0.00filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—2,474 at $0.00filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,868 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$84K9,000 at $9.31filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—238 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$110K11,799 at $9.31filing
21 Aug 2026filed 25 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$153K10,762 at $14.20filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—9,000 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—11,799 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—10,762 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—238 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$3,380238 at $14.20filing
21 Aug 2026filed 25 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.2M31,799 at $69.09filing
21 Aug 2026filed 25 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.9M41,832 at $69.09filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—9,000 at $0.00filing
21 Aug 2026filed 25 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—11,799 at $0.00filing

Sectors

Health Care39

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Rajeev SaggarChief Medical Officer · Chief Medical Officer at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days
Sarah KreppChief Human Resource Officer · Also traded LQDA in the last 90 days